What are the consequences of the fourth case?
Mol Ther
.
2007 Aug;15(8):1401-2.
doi: 10.1038/sj.mt.6300263.
Author
Christopher Baum
PMID:
17646833
DOI:
10.1038/sj.mt.6300263
No abstract available
Publication types
Editorial
MeSH terms
Clinical Trials as Topic / adverse effects*
Genetic Therapy / adverse effects*
Genetic Vectors
Humans
London
Mutagenesis, Insertional
Paris
Severe Combined Immunodeficiency / drug therapy*